Optimizing Patient Outcomes in Pancreatic Cancer With Al B. Benson, MD, FACP, FASCO
Optimizing Patient Outcomes in Pancreatic Cancer With Al B. Benson, MD, FACP, FASCO is organized by i3 Health.
Release: August 20, 2020
Expiration: August 19, 2021
i3 Health designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities approved for AMA PRA Category 1 Credit™ from organizations accredited by ACCME. Physician assistants may receive a maximum of 0.25 hours of Category 1 credit for completing this program.
With 5-year survival rates of only 37% for local disease, 12% for regional disease, and 3% for distant disease, pancreatic cancer is one of the most aggressive forms of cancer and one of the most challenging to treat. Despite the development of novel treatment approaches, therapeutic options remain limited. In this episode of Oncology Data Advisor, Al B. Benson, MD, Professor of Medicine at Northwestern University’s Feinberg School of Medicine and Associate Director for Cooperative Groups at Northwestern’s Robert H. Lurie Comprehensive Cancer Center, joins i3 Health for a discussion that covers recent developments in genomic testing and targeted therapies, supportive care measures that can optimize quality of life, and strategies that members of the cancer care team can utilize to improve the outcomes of their patients with pancreatic cancer.
Upon completion of this activity, participants should be able to:
• Identify the role that biomarkers can play in predicting therapeutic efficacy and developing tailored approaches to treatment
• Develop effective multidisciplinary approaches that can be used to enhance pancreatic cancer treatment and supportive care
Al B. Benson, MD, FACP, FASCO, Professor of Medicine, Northwestern University Feinberg School of Medicine
- CME : 0.25
- MOC : 0.25
- Hours : 0.25
Social Media Info :
Oncologists, gastroenterologists, oncology advanced practitioners, and other health care professionals involved in the treatment of patients with pancreatic cancer.
Number of Health Care Professionals Registered: 8 Number
Toll free Number
Browse CME / CE Conferences by Specialty View All
- Clinical Pharmacology
- Emergency Medicine
- Endocrinology, Metabolism and Diabetes
- Healthcare Management
- Infectious Disease
- Medical Education
- Obstetrics and Gynecology
- Pain Management
- Pharmacy and Medicine
- Primary Care
- Pulmonary Medicine